In clinical trials, the drug was shown to almost double the median survival time for patients with pancreatic cancer.

The new oral medication, daraxonrasib, has been shown to meaningfully extend the lives of patients with late-stage pancreatic ...

Researchers are testing CAR T-cell therapy as a treatment for lupus, Graves’ disease and other conditions in which the body’s ...

A common blood pressure drug may help a major class of cancer therapies work far better than expected. A widely prescribed ...

Knowable Magazine reports that many cancer survivors, like Kara Kenan, face ongoing health challenges post-treatment, but ...

Patients — and their doctors — have been desperate for a more effective pancreatic cancer treatment for decades. Now one ...

Last month, Revolution Medicines’ RAS inhibitor doubled survival in a Phase 3 pancreatic cancer trial. On the biotech’s heels are Immuneering, Actuate Therapeutics, Erasca and more, looking to improve ...

A proof-of-concept study has created a blueprint for producing prostate cancer treatment more efficiently. Researchers at the University of Missouri, Cancer Targeted Technology (CTT) and ...

A drug widely used to treat asthma and allergies may also help fight aggressive cancers, reports a new Northwestern Medicine ...

Many young adults who have been treated for cancer experience sexual problems. This is shown in a doctoral dissertation at Karolinska Institutet, which also highlights gaps in information provided by ...